|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2003-12-3
|
|
pubmed:abstractText |
Our objective was to determine the activity in terms of response rate, surgical resectability, and the tolerability of the new three-drug combination gemcitabine-cisplatin-paclitaxel (GCP) in unresectable stage IIIA(N2) and IIIB non-small cell lung cancer (NSCLC).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0169-5002
|
|
pubmed:author |
pubmed-author:AndruccettiMicheleM,
pubmed-author:BartoliniStefaniaS,
pubmed-author:BenedettiGiovanniG,
pubmed-author:CalandriCesareC,
pubmed-author:CappuzzoFedericoF,
pubmed-author:CortesiEnricoE,
pubmed-author:CrinòLucioL,
pubmed-author:De MarinisFilippoF,
pubmed-author:MaestriAntonioA,
pubmed-author:MartelliOlgaO,
pubmed-author:MigliorinoMaria RitaMR,
pubmed-author:NelliFabrizioF,
pubmed-author:RastelliFrancescaF
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
42
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
355-61
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:14644524-Adult,
pubmed-meshheading:14644524-Aged,
pubmed-meshheading:14644524-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:14644524-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:14644524-Cisplatin,
pubmed-meshheading:14644524-Deoxycytidine,
pubmed-meshheading:14644524-Female,
pubmed-meshheading:14644524-Humans,
pubmed-meshheading:14644524-Lung Neoplasms,
pubmed-meshheading:14644524-Male,
pubmed-meshheading:14644524-Middle Aged,
pubmed-meshheading:14644524-Neoplasm Staging,
pubmed-meshheading:14644524-Paclitaxel,
pubmed-meshheading:14644524-Treatment Outcome
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Phase II study of gemcitabine-cisplatin-paclitaxel triplet as induction chemotherapy in inoperable, locally-advanced non-small cell lung cancer.
|
|
pubmed:affiliation |
Division of Medical Oncology, Bellaria Hospital, Via Altura 3, 40139 Bologna, Italy. federico.cappuzzo@ausl.bo.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study,
Clinical Trial, Phase II
|
